Provided by Tiger Trade Technology Pte. Ltd.

Plus Therapeutics, Inc.

0.2983
-0.0094-3.05%
Volume:2.46M
Turnover:763.97K
Market Cap:53.21M
PE:-0.65
High:0.3280
Open:0.3100
Low:0.2952
Close:0.3077
52wk High:2.08
52wk Low:0.1634
Shares:178.37M
Float Shares:178.37M
Volume Ratio:1.56
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4560
EPS(LYR):-1.9544
ROE:-522.50%
ROA:-65.58%
PB:10.53
PE(LYR):-0.15

Loading ...

Feb 06, 2020

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Jan 03, 2020

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Dec 19, 2019

Major Issues Report

Current report, item 8.01
Dec 18, 2019

Major Issues Report

Current report, item 8.01
Nov 27, 2019

Major Issues Report

Current report, item 5.02
Nov 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 08, 2019

Major Issues Report

Current report, item 5.02
Oct 15, 2019

Major Issues Report

Current report, item 8.01
Oct 07, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Oct 03, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Sep 27, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Sep 23, 2019

Major Issues Report

Current report, item 8.01
Sep 23, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 20, 2019

Correspondence

[Cover]Correspondence
Sep 19, 2019

Correspondence

[Cover]Correspondence
Sep 16, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Sep 16, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Sep 10, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 10, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Aug 26, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals